PIC-ID Platform
Broad-spectrum infectious disease detection
Key Facts
About Pictura Bio
Pictura Bio is pioneering a novel point-of-care diagnostic platform called PIC-ID, which aims to deliver pathogen identification results in approximately one minute. The technology combines a single-reagent assay, a compact fluorescence microscopy reader (VISTA), and AI-powered image analysis to provide rapid, multiplexed infectious disease testing. Targeting the significant delays and costs associated with traditional lab tests, the company seeks to transform emergency and primary care by enabling immediate, data-backed treatment decisions. Backed by investors like Ahren, IQ Capital, and Science Creates, Pictura Bio is developing its suite of technologies to scale diagnostics directly to frontline healthcare settings.
View full company profile